PHASE II UNCONTROLLED OPEN-LABEL CLINICAL TRIAL, DETECTING SAFETY, AND NON-SPECIFIC THERAPEUTIC BENEFITS OF BEE VENOM PRODUCT ABEVAC
Journal of the Egyptian Society of Parasitology · 01.04.2026 · 56 (1) · 69-78
DOI: 10.21608/jesp.2026.503635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Egyptian Society of Parasitology, online erschienen am 01.04.2026. Verfasst von ABIR A. EL-FIKY und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
EL-FIKY, A. A., ELFEEL, S. S., MOHAMADY, M., ELMARAKBY, M. A., YEHIA, S. K., AFIFI, D. A., SHAHEEN, N. M. A., HAMMODA, E. E., ELFATTAH, D. M. A., & MORSY, T. A. (2026). PHASE II UNCONTROLLED OPEN-LABEL CLINICAL TRIAL, DETECTING SAFETY, AND NON-SPECIFIC THERAPEUTIC BENEFITS OF BEE VENOM PRODUCT ABEVAC. Journal of the Egyptian Society of Parasitology, 56(1), 69-78. https://doi.org/10.21608/jesp.2026.503635
Vancouver
EL-FIKY AA, ELFEEL SS, MOHAMADY M, ELMARAKBY MA, YEHIA SK, AFIFI DA, et al. PHASE II UNCONTROLLED OPEN-LABEL CLINICAL TRIAL, DETECTING SAFETY, AND NON-SPECIFIC THERAPEUTIC BENEFITS OF BEE VENOM PRODUCT ABEVAC. Journal of the Egyptian Society of Parasitology. 2026;56(1):69-78. doi:10.21608/jesp.2026.503635
BibTeX
@article{ELFIKY2026,
author = {EL-FIKY, ABIR A. and ELFEEL, SHERIF S. and MOHAMADY, MOSTAFA and ELMARAKBY, MOHAMMED A. and YEHIA, SHYMAA K. and AFIFI, DINA A. and SHAHEEN, NOHA M. A. and HAMMODA, EMAN E. and ELFATTAH, DOAA M. ABD and MORSY, TOSSON A.},
title = {PHASE II UNCONTROLLED OPEN-LABEL CLINICAL TRIAL, DETECTING SAFETY, AND NON-SPECIFIC THERAPEUTIC BENEFITS OF BEE VENOM PRODUCT ABEVAC},
journal = {Journal of the Egyptian Society of Parasitology},
year = {2026},
volume = {56},
number = {1},
pages = {69--78},
doi = {10.21608/jesp.2026.503635}
}
EUVIMED